Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,704.40
(
-0.02%
)
Dow Jones
49,652.14
(
0.00%
)
Brent Oil
109.68
(
-0.61%
)
Bitcoin
77,680.45
(
1.77%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122916
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 203608

Tuesday, 03/13/2018 4:55:51 PM

Tuesday, March 13, 2018 4:55:51 PM

Post# of 257473
EARS -31%/AH on second phase-3 failure in tinnitus:

https://finance.yahoo.com/news/auris-medical-provides-business-201545128.html

It’s surprising that enough people expected success for the stock to be down so much in AH trading. The second phase-3 trial was not much different from the first phase-3 that failed, and neither of them was based on successful phasse-2 data (#msg-124612678).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today